All Slides Sexually Transmitted Disease Surveillance 2001 Division of STD Prevention.

All Slides

Sexually Transmitted Disease Surveillance 2001

Division of STD Prevention

Chlamydia



Chlamydia — Number of states that require reporting of Chlamydia trachomatis infections: United States, 1987–2001

No. of states

0

10

20

30

40

50

1987 88 89 90 91 92 93 94 95 96 97 98 99 2000 01

Chlamydia — Reported rates: United States, 1984–2001

Rate (per 100,000 population)

0

60

120

180

240

300

1984 86 88 90 92 94 96 98 2000

Chlamydia — Rates by state: United States and outlying areas, 2001

Note: The total rate of chlamydia for the United States and outlying areas (including Guam, Puerto Rico and Virgin Islands) was 275.5 per 100,000 population.

Rate per 100,000population

<=150150.1-300>300

VT 104.8 NH 111.9 MA 163.8 RI 277.8 CT 226.6 NJ 193.9 DE 356.4 MD 295.3

Guam 278.4

Puerto Rico 72.2 Virgin Is. 120.6

(n= 7)(n= 29)(n= 17)

326.6

437.7

279.6272.3

301.0 307.8

235.4

413.4

332.7

156.3

352.0 250.9

194.7

225.0219.7

399.2

104.9

312.8

169.2

414.6

249.3

212.7

187.3241.8

343.8

244.5

274.6

165.4

331.7

303.7

217.9

231.0

382.1

241.2

273.5

334.5

134.5

259.1

231.3

129.7

303.6

169.9

Chlamydia — Rates by region: United States, 1984–2001


WestMidwestNortheastSouth

0

70

140

210

280

350

1984 86 88 90 92 94 96 98 2000

Chlamydia — Rates by sex: United States, 1984–2001


MenWomen

0

90

180

270

360

450

1984 86 88 90 92 94 96 98 2000

Chlamydia — Age- and sex-specific rates: United States, 2001

Men Rate (per 100,000 population) Women

Age3,000 2,400 1,800 1,200 600 0 0 600 1,200 1,800 2,400 3,000

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14 9.9


Age3,000 2,400 1,800 1,200 600 0 0 600 1,200 1,800 2,400 3,000

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

375.9


Age3,000 2,400 1,800 1,200 600 0 0 600 1,200 1,800 2,400 3,000

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

604.9


Age3,000 2,400 1,800 1,200 600 0 0 600 1,200 1,800 2,400 3,000

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

284.7


Age3,000 2,400 1,800 1,200 600 0 0 600 1,200 1,800 2,400 3,000

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

140.4


Age3,000 2,400 1,800 1,200 600 0 0 600 1,200 1,800 2,400 3,000

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

70.3


Age3,000 2,400 1,800 1,200 600 0 0 600 1,200 1,800 2,400 3,000

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

37.1


Age3,000 2,400 1,800 1,200 600 0 0 600 1,200 1,800 2,400 3,000

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

15.9


Age3,000 2,400 1,800 1,200 600 0 0 600 1,200 1,800 2,400 3,000

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

5.5


Age3,000 2,400 1,800 1,200 600 0 0 600 1,200 1,800 2,400 3,000

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

2.2


Age3,000 2,400 1,800 1,200 600 0 0 600 1,200 1,800 2,400 3,000

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

114.2


Age3,000 2,400 1,800 1,200 600 0 0 600 1,200 1,800 2,400 3,000

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14 139.8


Age3,000 2,400 1,800 1,200 600 0 0 600 1,200 1,800 2,400 3,000

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

2,536.1


Age3,000 2,400 1,800 1,200 600 0 0 600 1,200 1,800 2,400 3,000

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

2,447.0


Age3,000 2,400 1,800 1,200 600 0 0 600 1,200 1,800 2,400 3,000

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

824.6


Age3,000 2,400 1,800 1,200 600 0 0 600 1,200 1,800 2,400 3,000

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

301.9


Age3,000 2,400 1,800 1,200 600 0 0 600 1,200 1,800 2,400 3,000

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

119.1


Age3,000 2,400 1,800 1,200 600 0 0 600 1,200 1,800 2,400 3,000

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

51.4


Age3,000 2,400 1,800 1,200 600 0 0 600 1,200 1,800 2,400 3,000

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

18.1


Age3,000 2,400 1,800 1,200 600 0 0 600 1,200 1,800 2,400 3,000

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

5.1


Age3,000 2,400 1,800 1,200 600 0 0 600 1,200 1,800 2,400 3,000

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

2.9


Age3,000 2,400 1,800 1,200 600 0 0 600 1,200 1,800 2,400 3,000

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

436.3

Chlamydia — Positivity among 15-24 year old women tested in family planning clinics by state: United States and outlying areas,

2001

Positivity (%)

<44.0-4.9>=5

VT 3.4 NH 5.9 MA 5.2 RI 7.0 CT 5.0 NJ 6.3 DE 5.8 MD 5.1 DC 6.1


(n= 8)(n= 8)(n= 37)

7.7

3.7

5.6 6.6

6.5 5.0

5.5

8.3

5.4

4.4

7.0 5.4

4.3

4.1 3.9

10.8

3.1

5.5

4.3

13.5

4.3

5.8

3.8 7.5

6.7

5.2

6.9

3.2

5.7

6.0

4.0

5.6

7.6

3.4

4.9

8.4

5.1

8.1

6.2

2.7

7.5

4.2

Note: States reported chlamydia positivity data on at least 500 women aged 15-24 years screened during 2001.

SOURCE: Regional Infertility Prevention Program; Office of Population Affairs; Local and State STD Control Programs; Centers for Disease Control and Prevention

Chlamydia — Trends in positivity among 15-44 year old women tested in family planning clinics by HHS regions, 1988–2001

Note: Trends adjusted for changes in laboratory test method and associated increases in test sensitivity. No data on laboratory test method available for Region VII in 1995 and Regions IV and V in 1996.


IX

XVIII

VII

VI

V

IV

III

III

Region IRegion II

Region III

Region IV

Region V

Region VIRegion VII

Region VIII

Region IX

Region X 97 98 99 00 01

5.7 6.2 6.2 6.47.3

96 97 98 99 00 01

6.74.9 4.6 4.1 4.9 5.1

96 97 98 99 00 019594

7.46.0 5.3 5.6 6.0 6.3 6.0 5.5

97 98 99 00 01

8.910.1 9.5

8.6 8.5

97 98 99 00 01

5.6

7.5 7.2 7.1 6.6

96 97 98 99 00 01

8.4 8.9 9.78.7 8.8 8.5

96 97 98 99 00 01

4.9 4.7 5.4 5.3 5.5 5.4

96 97 98 99 00 0194 95

6.05.0 4.6 4.6 5.3 5.4 5.6 6.0

96 97 98 99 00 01

5.1 5.25.9 6.3 6.2 6.3

96 97 98 99 00 0194 95939291908988

13.0

10.0 9.58.0

6.75.0 4.7 4.1 3.9 3.9 4.6 4.9 5.3 5.3

Gonorrhea



Gonorrhea — Reported rates: United States, 1970–2001 and the Healthy People year 2010 objective

R ate (per 100,000 population)

G onorrhea2010 O bjective

0

100

200

300

400

500

1970 73 76 79 82 85 88 91 94 97 2000

Note: The Healthy People 2010 (HP2010) objective for gonorrhea is 19.0 cases per 100,000 population.

Gonorrhea — Rates by state: United States and outlying areas, 2001

Note: The total rate of gonorrhea for the United States and outlying areas (including Guam, Puerto Rico and Virgin Islands) was 126.9 per 100,000 population. The Healthy People year 2010 objective is 19.0 per 100,000 population.

R ate per 100,000popu la tion

<2020-100>100

V T 12 .5 N H 14 .2 M A 50 .6 R I 79 .2 C T 74 .8 N J 106 .0 D E 221 .2 M D 178 .0

Guam 31.0

P uerto R ico 15 .5 V irg in Is . 31 .3

(n= 9 )(n= 21)(n= 23)

251.4

72 .9

76 .4172.2

68 .8 74 .2

134.7

231.1

49 .9

5 .9

193.4 114.7

48 .5

99 .3 88 .8

274.2

11 .1

172.3

54 .9

272.8

155.9

11 .5

69 .5 87 .9

57 .2

117.5

206.0

8 .7

186.4

138.6

33 .4

116.0

269.3

38 .3

178.3

144.0

9 .8

156.7

50 .7

40 .5

112.1

15 .6

Gonorrhea — Rates by region: United States, 1981–2001 and the Healthy People year 2010 objective


W estM idw estN ortheastSouth2010 O bjective

0

120

240

360

480

600

1981 83 85 87 89 91 93 95 97 99 2001

Gonorrhea — Rates by sex: United States, 1981–2001 and the Healthy People year 2010 objective


M aleFem ale2010 O bjective

0

120

240

360

480

600

1981 83 85 87 89 91 93 95 97 99 2001

Gonorrhea — Rates by race and ethnicity: United States, 1981–2001 and the Healthy People year 2010 objective


W hiteB lackH ispan icAsian/Pac Is lAm Ind /AK N at2010 O bjective

0

500

1,000

1,500

2,000

2,500

1981 83 85 87 89 91 93 95 97 99 2001

Gonorrhea — Age- and sex-specific rates: United States, 2001

M en R ate (per 100,000 population) W om en

Age750 600 450 300 150 0 0 150 300 450 600 750

Tota l 65+

55-64

45-5440-4435-39

30-3425-2920-2415-19

10-148.2


Age750 600 450 300 150 0 0 150 300 450 600 750

Tota l 65+

55-64

45-5440-4435-39

30-3425-2920-2415-19

10-14307.5


Age750 600 450 300 150 0 0 150 300 450 600 750

Tota l 65+

55-64

45-5440-4435-39

30-3425-2920-2415-19

10-14

563.6


Age750 600 450 300 150 0 0 150 300 450 600 750

Tota l 65+

55-64

45-5440-4435-39

30-3425-2920-2415-19

10-14

328.4


Age750 600 450 300 150 0 0 150 300 450 600 750

Tota l 65+

55-64

45-5440-4435-39

30-3425-2920-2415-19

10-14

203.9


Age750 600 450 300 150 0 0 150 300 450 600 750

Tota l 65+

55-64

45-5440-4435-39

30-3425-2920-2415-19

10-14

134.3


Age750 600 450 300 150 0 0 150 300 450 600 750

Tota l 65+

55-64

45-5440-4435-39

30-3425-2920-2415-19

10-14

90.5


Age750 600 450 300 150 0 0 150 300 450 600 750

Tota l 65+

55-64

45-5440-4435-39

30-3425-2920-2415-19

10-14

46.8


Age750 600 450 300 150 0 0 150 300 450 600 750

Tota l 65+

55-64

45-5440-4435-39

30-3425-2920-2415-19

10-14

17.2


Age750 600 450 300 150 0 0 150 300 450 600 750

Tota l 65+

55-64

45-5440-4435-39

30-3425-2920-2415-19

10-14

4.5


Age750 600 450 300 150 0 0 150 300 450 600 750

Tota l 65+

55-64

45-5440-4435-39

30-3425-2920-2415-19

10-14

128.6


Age750 600 450 300 150 0 0 150 300 450 600 750

Tota l 65+

55-64

45-5440-4435-39

30-3425-2920-2415-19

10-14 51.8


Age750 600 450 300 150 0 0 150 300 450 600 750

Tota l 65+

55-64

45-5440-4435-39

30-3425-2920-2415-19

10-14703.2


Age750 600 450 300 150 0 0 150 300 450 600 750

Tota l 65+

55-64

45-5440-4435-39

30-3425-2920-2415-19

10-14

664.1


Age750 600 450 300 150 0 0 150 300 450 600 750

Tota l 65+

55-64

45-5440-4435-39

30-3425-2920-2415-19

10-14

249.4


Age750 600 450 300 150 0 0 150 300 450 600 750

Tota l 65+

55-64

45-5440-4435-39

30-3425-2920-2415-19

10-14

112.7


Age750 600 450 300 150 0 0 150 300 450 600 750

Tota l 65+

55-64

45-5440-4435-39

30-3425-2920-2415-19

10-14

57.8


Age750 600 450 300 150 0 0 150 300 450 600 750

Tota l 65+

55-64

45-5440-4435-39

30-3425-2920-2415-19

10-14

31.2


Age750 600 450 300 150 0 0 150 300 450 600 750

Tota l 65+

55-64

45-5440-4435-39

30-3425-2920-2415-19

10-14

9.4


Age750 600 450 300 150 0 0 150 300 450 600 750

Tota l 65+

55-64

45-5440-4435-39

30-3425-2920-2415-19

10-14

2.0


Age750 600 450 300 150 0 0 150 300 450 600 750

Tota l 65+

55-64

45-5440-4435-39

30-3425-2920-2415-19

10-14

0.9


Age750 600 450 300 150 0 0 150 300 450 600 750

Tota l 65+

55-64

45-5440-4435-39

30-3425-2920-2415-19

10-14

128.5

Gonorrhea — Positivity among 15-24 year old women tested in family planning clinics by state: United States and outlying areas,

2001

P ositiv ity (% )

S ee *<11.0-1 .9>=2

VT 0 .2 N H 0 .4 M A R I C T 1 .0 N J 1 .3 D E M D D C 1 .3

P uerto R ico 0 .1 V irg in Is . 1 .6

(n= 16 )(n= 17 )(n= 15 )(n= 5)

1 .9

0 .2

1 .6

1 .1 0 .3

1 .2

2 .2

0 .1

1 .7 0 .8

0 .9

0 .7 0 .5

2 .9

1 .2

3 .2

0 .8

1 .1

0 .5 2 .3

0 .4

1 .0

0 .8 1 .3

0 .7

1 .3

0 .4 2 .5

1 .7

0 .9

*States reported gonorrhea positivity data on less than 500 women aged 15-24 years during 2001.


Gonococcal Isolate Surveillance Project (GISP) — Location of participating clinics and regional laboratories: United States, 2001

Tripler AMC

Gonococcal Isolate Surveillance Project (GISP) — Penicillin and tetracycline resistance among GISP isolates, 2001

Note: PPNG=penicillinase-producing N. gonorrhoeae; TRNG=plasmid-mediated tetracycline resistant N. gonorrhoeae; PPNG-TRNG=plasmid-mediated penicillin and tetracycline resistant N. gonorrhoeae; PenR=chromosomally mediated penicillin resistant N. gonorrhoeae; TetR=chromosomally mediated tetracycline resistant N. gonorrhoeae; CMRNG=chromosomally mediated penicillin and tetracycline resistant N. gonorrhoeae.

S usceptib le

P P N G

TR N G

P P N G /TR N G

P enR

TetR

C M R N G

79.1%

1.5%

5.2%

0.5%2.9%

4.4%

6.4%

Gonococcal Isolate Surveillance Project (GISP) — Percent of Neisseria gonorrhoeae isolates with resistance or intermediate

resistance to ciprofloxacin, 1990–2001

Note: Resistant isolates have ciprofloxacin MICs >1 g/mL. Isolates with intermediate resistance have ciprofloxacin MICs of 0.125 - 0.5 g/mL. Susceptibility to ciprofloxacin was first measured in GISP in 1990.

Percent

R esistance

Interm ediate resistance

0.0

0.6

1.2

1.8

2.4

3.0

1990 91 92 93 94 95 96 97 98 99 2000 01

Gonococcal Isolate Surveillance Project (GISP) — Percent of men with gonorrhea who had a previous gonorrhea infection, 1991–2001

Percent

Ever*Last 12 m onths**

0

10

20

30

40

50

1991 92 93 94 95 96 97 98 99 2000 01

*Data first collected in 1991.

**Data first collected in 1992.

Syphilis



Syphilis — Reported cases by stage of illness: United States, 1941–2001

Thousands of cases

P&SEarly LatentTotal Syphilis

0

120

240

360

480

600

1941 46 51 56 61 66 71 76 81 86 91 96 2001

Primary and secondary syphilis — Reported rates: United States, 1970–2001 and the Healthy People year 2010 objective


P&S Syphilis2010 Objective

0

5

10

15

20

25

1970 73 76 79 82 85 88 91 94 97 2000

Note: The Healthy People 2010 (HP2010) objective for primary and secondary syphilis is 0.2 case per 100,000 population.

Primary and secondary syphilis — Rates by state: United States and outlying areas, 2001

Note: The total rate of primary and secondary syphilis for the United States and outlying areas (including Guam, Puerto Rico and Virgin Islands) was 2.2 per 100,000 population. The Healthy People year 2010 objective is 0.2 per 100,000 population.


<=.2.21-4>4


Guam 7.8


(n= 10)(n= 34)(n= 9)

3.2

0.0

3.5 1.8

1.6 0.5

3.0

5.1

1.0

0.1

3.3 2.5

0.2

0.9 1.2

3.9

0.1

4.3

0.7

4.9

0.5

0.0

0.6 0.4

1.0

1.6

5.5

0.0

0.7

1.7

0.4

0.8

5.9

0.1

5.8

2.3

0.5

1.4

1.0

0.3

0.4

0.2

Primary and secondary syphilis — Counties with rates above and counties with rates below the Healthy People year 2010 objective:

United States, 2001

Rate per 100,000Population

<=0.2>0.2

(n=2,533)(n=606)

Primary and secondary syphilis — Rates by region: United States, 1981–2001 and the Healthy People year 2010 objective


WestMidwestNortheastSouth2010 Objective

0

10

20

30

40

50

1981 83 85 87 89 91 93 95 97 99 2001

Primary and secondary syphilis — Rates by sex: United States, 1981–2001 and the Healthy People year 2010 objective


MaleFemale2010 Objective

0

5

10

15

20

25

1981 83 85 87 89 91 93 95 97 99 2001

Primary and secondary syphilis — Rates by race and ethnicity: United States, 1981–2001 and the Healthy People year 2010

objective


WhiteBlackHispanicAsian/Pac IslAm Ind/AK Nat2010 Objective

0

30

60

90

120

150

1981 83 85 87 89 91 93 95 97 99 2001

Primary and secondary syphilis — Male to female rate ratios: United States, 1981–2001

Male-Female rate ratio

0

1:1

2:1

3:1

4:1

5:1

1981 83 85 87 89 91 93 95 97 99 2001

Primary and secondary syphilis — Age- and sex-specific rates: United States, 2001


Age7.5 6.0 4.5 3.0 1.5 0.0 0.0 1.5 3.0 4.5 6.0 7.5

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-140.0


Age7.5 6.0 4.5 3.0 1.5 0.0 0.0 1.5 3.0 4.5 6.0 7.5

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

1.4


Age7.5 6.0 4.5 3.0 1.5 0.0 0.0 1.5 3.0 4.5 6.0 7.5

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

5.0


Age7.5 6.0 4.5 3.0 1.5 0.0 0.0 1.5 3.0 4.5 6.0 7.5

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

5.9


Age7.5 6.0 4.5 3.0 1.5 0.0 0.0 1.5 3.0 4.5 6.0 7.5

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

6.4


Age7.5 6.0 4.5 3.0 1.5 0.0 0.0 1.5 3.0 4.5 6.0 7.5

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

7.2


Age7.5 6.0 4.5 3.0 1.5 0.0 0.0 1.5 3.0 4.5 6.0 7.5

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

5.3


Age7.5 6.0 4.5 3.0 1.5 0.0 0.0 1.5 3.0 4.5 6.0 7.5

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

3.4


Age7.5 6.0 4.5 3.0 1.5 0.0 0.0 1.5 3.0 4.5 6.0 7.5

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

1.4


Age7.5 6.0 4.5 3.0 1.5 0.0 0.0 1.5 3.0 4.5 6.0 7.5

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

0.4


Age7.5 6.0 4.5 3.0 1.5 0.0 0.0 1.5 3.0 4.5 6.0 7.5

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

3.0


Age7.5 6.0 4.5 3.0 1.5 0.0 0.0 1.5 3.0 4.5 6.0 7.5

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14 0.2


Age7.5 6.0 4.5 3.0 1.5 0.0 0.0 1.5 3.0 4.5 6.0 7.5

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

2.5


Age7.5 6.0 4.5 3.0 1.5 0.0 0.0 1.5 3.0 4.5 6.0 7.5

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

3.8


Age7.5 6.0 4.5 3.0 1.5 0.0 0.0 1.5 3.0 4.5 6.0 7.5

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

3.1


Age7.5 6.0 4.5 3.0 1.5 0.0 0.0 1.5 3.0 4.5 6.0 7.5

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

3.0


Age7.5 6.0 4.5 3.0 1.5 0.0 0.0 1.5 3.0 4.5 6.0 7.5

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

2.9


Age7.5 6.0 4.5 3.0 1.5 0.0 0.0 1.5 3.0 4.5 6.0 7.5

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

2.0


Age7.5 6.0 4.5 3.0 1.5 0.0 0.0 1.5 3.0 4.5 6.0 7.5

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

0.9


Age7.5 6.0 4.5 3.0 1.5 0.0 0.0 1.5 3.0 4.5 6.0 7.5

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

0.2


Age7.5 6.0 4.5 3.0 1.5 0.0 0.0 1.5 3.0 4.5 6.0 7.5

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

0.0


Age7.5 6.0 4.5 3.0 1.5 0.0 0.0 1.5 3.0 4.5 6.0 7.5

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

1.4

Congenital syphilis — Reported cases for infants <1 year of age and rates of primary and secondary syphilis among women:

United States, 1970–2001

Kaufman Criteria

CDC SurveillanceDefinition

P&S rate (per 100,000 population) CS cases (in thousands)

P&S Syphilis

CongenitalSyphilis

0

4

8

12

16

20

1970 75 80 85 90 95 2000

0.0

1.5

3.0

4.5

6.0

7.5

Note: The surveillance case definition for congenital syphilis changed in 1988.

Congenital syphilis — Rates for infants <1 year of age: United States, 1981–2001 and the Healthy People year 2010 objective

Rate (per 100,000 live births)

Cong. Syphilis2010 Objective

0

25

50

75

100

125

1981 83 85 87 89 91 93 95 97 99 2001

Note: The Healthy People 2010 (HP2010) objective for primary and secondary syphilis is 0.2 case per 100,000 population. The surveillance case definition for congenital syphilis changed in 1988.

Other Sexually Transmitted Diseases



Chancroid — Reported cases: United States, 1981–2001

Cases (in thousands)

0

1

2

3

4

5

1981 83 85 87 89 91 93 95 97 99 2001

Genital herpes — Initial visits to physicians’ offices: United States, 1966–2001

Visits (in thousands)

0

50

100

150

200

250

1966 69 72 75 78 81 84 87 90 93 96 99

SOURCE: National Disease and Therapeutic Index (IMS America, Ltd.)

Genital herpes simplex virus type 2 infections — Percent seroprevalence according to age in NHANES* II (1976-1980) and

NHANES III (1988-1994)

Percent

NHANES IINHANES III

0

8

16

24

32

40

Age Group

12-19 20-29 30-39 40-49 50-59 60-69 70+

Note: Bars indicate 95% confidence intervals.

*National Health and Nutrition Examination Survey

Genital warts — Initial visits to physicians’ offices: United States, 1966–2001


0

80

160

240

320

400

1966 69 72 75 78 81 84 87 90 93 96 99


Nonspecific urethritis — Initial visits to physicians’ offices by men:United States, 1966–2001


0

80

160

240

320

400

1966 69 72 75 78 81 84 87 90 93 96 99


Trichomonal and other vaginal infections — Initial visits to physicians’ offices: United States, 1966–2001


TrichomonalOther Vaginitis

0

900

1,800

2,700

3,600

4,500

1966 69 72 75 78 81 84 87 90 93 96 99


STDs in Women and Infants



Chlamydia — Rates for women by state: United States and outlying areas, 2001

Note: The total rate of chlamydia for women in the United States and outlying areas (including Guam, Puerto Rico and Virgin Islands) was 430.8 per 100,000 population.


<=150150.1-300>300


Guam 458.8

Puerto Rico 117.1Virgin Is. 204.4

(n= 1)(n= 13)(n= 39)

581.4

654.2

435.6434.6

448.7 463.4

374.4

670.9

506.4

227.6

522.5 376.6

288.1

366.0342.7

625.1

158.9

484.7

242.0

697.3

412.3

323.8

290.5365.8

528.9

389.6

453.6

222.6

505.4

490.1

315.5

354.6

655.7

344.7

414.7

548.7

190.2

420.8

343.2

211.9

443.7

276.7

Gonorrhea — Rates for women by state: United States and outlying areas, 2001

Note: The total rate of gonorrhea for women in the United States and outlying areas (including Guam, Puerto Rico and Virgin Islands) was 126.6 per 100,000 population. The Healthy People year 2010 objective is 19.0 per 100,000 population for women.


<2020-100>100


Guam 29.1


(n= 9)(n= 20)(n= 24)

248.3

80.6

66.2175.6

61.5 74.4

126.8

230.6

48.4

6.0

192.1 122.4

51.4

107.9 87.7

262.6

8.4

178.8

58.8

317.0

157.9

12.6

77.3 77.6

51.0

120.8

190.2

9.3

192.7

152.2

26.0

123.9

248.5

43.7

164.7

148.6

8.5

152.1

44.0

45.0

135.3

17.5

Primary and secondary syphilis — Rates for women by state: United States and outlying areas, 2001

Note: The total rate of primary and secondary syphilis for women in the United States and outlying areas (including Guam, Puerto Rico and Virgin Islands) was 1.4 per 100,000 population. The Healthy People year 2010 objective is 0.2 per 100,000 population.


<=.2.21-4>4


Guam 6.6


(n= 22)(n= 24)(n= 7)

2.9

0.0

1.92.0

0.2 0.2

1.6

3.1

0.0

0.0

1.4 2.3

0.1

0.8 0.8

3.6

0.0

3.2

0.6

4.7

0.3

0.0

0.9 0.1

0.6

0.2

4.7

0.0

0.4

1.6

0.1

0.4

4.9

0.0

5.4

1.6

0.2

1.2

0.2

0.1

0.5

0.4

Congenital syphilis — Rates for infants <1 year of age by state: United States and outlying areas, 2001

Note: The total rate of congenital syphilis for infants <1 year of age for the United States and outlying areas (including Guam, Puerto Rico and Virgin Islands) was 11.5 per 100,000 live births. The Healthy People year 2010 objective is 1.0 per 100,000 live births.

Rate per 100,000live births

<11-40>40


Guam 24.9


(n= 24)(n= 28)(n= 1)

9.7

0.0

35.7 16.3

11.4 1.6

18.8

14.2

0.0

0.0

22.0 15.1

0.0

5.2 1.8

0.0

0.0

3.0

0.0

21.1

6.6

0.0

0.00.0

0.0

12.9

16.7

0.0

0.7

10.2

0.0

2.8

29.1

0.0

18.0

20.9

0.0

2.1

0.0

0.0

0.0

0.0

Congenital syphilis — Cases by prenatal care utilization: United States, 1995-2001

Cases

Prenatal

No prenatal

Unknown

0

240

480

720

960

1,200

1995 1996 1997 1998 1999 2000 2001

Chlamydia — Positivity among 15-24 year old women tested in prenatal clinics by state: United States and outlying areas, 2001

Positivity (%)

See *<55.0-9.9>=10

VT NH MA RI CT NJ DE 8.7 MD 3.9 DC

Puerto Rico 8.9 Virgin Is.

(n= 30)(n= 6)(n= 13)(n= 4)

11.0

8.0

6.6

7.7

4.8

7.1 3.8

13.5

13.5

7.1

5.4 3.7

7.5

8.1

7.4

4.5

8.6

6.7

11.1 4.4

*States not reporting chlamydia positivity data in prenatal clinics.Note: States reported chlamydia positivity data on at least 100 women aged 15-24 years during 2001.


Gonorrhea — Positivity among 15-24 year old women tested in prenatal clinics by state: United States and outlying areas, 2001

Positivity (%)

See *<11.0-1.9>=2

VT NH MA RI CT NJ DE MD DC

Puerto Rico Virgin Is.

(n= 37)(n= 9)(n= 2)(n= 5)

2.7

1.3

0.7

1.5

0.9 0.6

3.9

3.1

0.4

0.80.0

0.2 0.9

2.0

0.7

4.3

*States not reporting gonorrhea positivity data in prenatal clinics.Note: States reported gonorrhea positivity data on at least 100 women aged 15-24 years during 2001.


Ectopic pregnancy — Hospitalizations of women 15-44 years of age: United States, 1980-2000

Ectopic Pregnancies (in thousands)

0

20

40

60

80

100

1980 82 84 86 88 90 92 94 96 98 2000

Note: Some variations in 1981 and 1988 numbers may be due to changes in sampling procedures. The relative standard error for these estimates ranges from 8% to 11%.

SOURCE: National Hospital Discharge Survey (National Center for Health Statistics, CDC)

Pelvic inflammatory disease — Hospitalizations of women 15-44 years of age: United States, 1980–2000

Hospitalizations (in thousands)

Acute, Unspec.Chronic

0

40

80

120

160

200

1980 82 84 86 88 90 92 94 96 98 2000

Note: The relative standard error for the estimates of the overall total number of PID cases range from 6% to 9%.

SOURCE: National Hospital Discharge Survey (National Center for Health Statistics, CDC)

Pelvic inflammatory disease — Initial visits to physicians’ offices by women 15-44 years of age: United States, 1980–2001


0

100

200

300

400

500

1980 82 84 86 88 90 92 94 96 98 2000


STD’s in Adolescents and Young Adults



Chlamydia — Positivity among women tested in family planning clinics by age group: Region X, 1988–2001

Percent

<18 Years18-19 Years20-24 Years25-29 Years30+ Years

0

3

6

9

12

15

1988 89 90 91 92 93 94 95 96 97 98 99 2000 01

Note: Women who met screening criteria were tested. Trends not adjusted for changes in laboratory test method and associated increases in test sensitivity in 1994 and 1999–2001.

SOURCE: Regional Infertility Prevention Program: Region X Chlamydia Project (Alaska, Idaho, Oregon and Washington)

Chlamydia — Prevalence among 16-24 year-old women entering the National Job Training Program by state of residence: United States

and outlying areas, 2001

Prevalence (%)

See *<1010.0-14.9>=15

VT NH MA 9.9 RI CT NJ 13.9 DE MD 13.4 DC


(n= 26)(n= 9)(n= 17)(n= 1)

13.8

11.2 13.7

7.6

13.2

12.8

9.5 5.1

10.3

8.8

10.6

18.0

10.1

9.6

11.8

10.7

10.3

6.2

11.5

12.3

13.5

10.1

9.6

*Fewer than 100 women residing in these states and entering the National Job Training Program were screened for chlamydia in 2001.Note: The overall chlamydia prevalence among female students entering the National Job Training Program in 2001 was 10.8%.

SOURCE: U.S. Department of Labor

Chlamydia — Adolescent Women Reproductive Health Monitoring Project chlamydia positivity by venue and project area, 2001

Note: Where data are missing for project areas and venues, no testing or fewer than 50 chlamydia tests were performed at the missing location in 2001.

Percent

Venues

Colorado

Connecticut

Minnesota

New York City

Wisconsin

0

8

16

24

32

40

-------- Schools -------- ------ Street Youth -----

Gonorrhea — Adolescent Women Reproductive Health Monitoring Project gonorrhea positivity by venue and project area, 2001

Note: Where data are missing for project areas and venues, no testing or fewer than 50 gonorrhea tests were performed in 2001.

Percent

Venues

Colorado

Connecticut

Minnesota

New York City

Wisconsin

0

3

6

9

12

15

-------- Schools -------- ------ Street Youth -----

Gonorrhea — Prevalence among 16-24 year-old women entering the National Job Training Program by state of residence: United States

and outlying areas, 2001

Prevalence (%)

See *<22.0-4.9>=5

VT NH MA 2.0 RI CT NJ DE MD DC


(n= 35)(n= 5)(n= 9)(n= 4)

8.1

2.4

0.8

5.3

6.1

3.6

4.6

4.8

3.8

1.4

4.6

5.9

1.1

4.1

3.1

0.7

*Fewer than 100 women residing in these states and entering the National Job Training Program were screened for gonorrhea by the national contract laboratory in 2001. Note: Many training centers test female students for gonorrhea using local laboratories; these results are not available to CDC. For this map, gonorrhea test results for students at centers submitting specimens to the national contract laboratory were included if the number of gonorrhea tests submitted was greater than 90% of the number of chlamydia tests submitted. The overall gonorrhea prevalence among female students entering the National Job Training Program in 2001 was 3.3%.

SOURCE: U.S. Department of Labor

Gonorrhea — Age-specific rates among women 10-44 years of age: United States, 1981–2001


10-1415-1920-2425-2930-3435-3940-44

0

300

600

900

1,200

1,500

1981 83 85 87 89 91 93 95 97 99 2001

Gonorrhea — Age-specific rates among men 10-44 years of age: United States, 1981–2001


10-1415-1920-2425-2930-3435-3940-44

0

400

800

1,200

1,600

2,000

1981 83 85 87 89 91 93 95 97 99 2001

Primary and secondary syphilis — Age-specific rates among women 10-44 years of age: United States, 1981–2001


10-1415-1920-2425-2930-3435-3940-44

0

15

30

45

60

75

1981 83 85 87 89 91 93 95 97 99 2001

Primary and secondary syphilis — Age-specific rates among men 10-44 years of age: United States, 1981–2001


10-1415-1920-2425-2930-3435-3940-44

0

15

30

45

60

75

1981 83 85 87 89 91 93 95 97 99 2001

STDs in Racial and Ethnic Minorities



Chlamydia — Positivity among women tested in family planning clinics by race and ethnicity: Region X, 1988–2001

Percent

W hiteB lackH ispanicAsian/Pac IslAm Ind/AK N at

0

3

6

9

12

15

1988 89 90 91 92 93 94 95 96 97 98 99 2000 01

Note: Women who met screening criteria were tested. Trends not adjusted for changes in laboratory test method and associated increases in test sensitivity in 1994, 1999–2001.

SOURCE: Regional Infertility Prevention Program: Region X Chlamydia Project (Alaska, Idaho, Oregon and Washington)

Chlamydia — Positivity among 15-30 year old women tested in Indian Health Service Clinics by IHS areas, 2001

*IHS areas not reporting chlamydia positivity data during 2001. Note: Albuquerque Area - chlamydia positivity data reported for January-October only.

SOURCE: Indian Health Service

Navajo Area*

Albuquerque Area6.9

Tucson Area*

California Area*

Portland Area*

Alaska Area*

Phoenix Area*

BillingsArea10.0

AberdeenArea8.6 Bemidji Area*

Nashville Area*

Oklahoma City Area3.1

Gonorrhea — Reported rates for 15-19 year old females by race and ethnicity: United States, 1981–2001


W hiteB lackH ispanicAsian/Pac Is lAm Ind/AK N at

0

1,400

2,800

4,200

5,600

7,000

1981 83 85 87 89 91 93 95 97 99 2001

Gonorrhea — Reported rates for 15-19 year old males by race and ethnicity: United States, 1981–2001



0

1,400

2,800

4,200

5,600

7,000

1981 83 85 87 89 91 93 95 97 99 2001

Primary and secondary syphilis — Reported rates for 15-19 year old females by race and ethnicity: United States, 1981–2001



0

50

100

150

200

250

1981 83 85 87 89 91 93 95 97 99 2001

Primary and secondary syphilis — Reported rates for 15-19 year old males by race and ethnicity: United States, 1981–2001



0

25

50

75

100

125

1981 83 85 87 89 91 93 95 97 99 2001

Congenital syphilis — Rates for infants <1 year of age by mother’s race and ethnicity: United States, 1991–2001 and the Healthy People

year 2010 objective

R ate (per 100,000 live b irths)

W hiteB lackH ispanicAsian/P ac Is lAm Ind/AK N at2010 O bjective

0

90

180

270

360

450

1991 92 93 94 95 96 97 98 99 2000 01

Note: Less than 5% of cases had missing race/ethnicity information and were excluded.

STDs Among Men Who Have Sex with Men



MSM Prevalence Monitoring Project — Median test positivity by clinic for gonorrhea, chlamydia, and HIV among MSM attending

STD clinics, by race/ethnicity, 2001

M edian positivity

W hite

B lack

H ispanic

0

5

10

15

20

25

U rethra lgonorrhea

R ecta lgonorrhea

Pharyngealgonorrhea

U rethra lch lam ydia

*H IV

*Excludes persons known to be HIV-positive.

MSM Prevalence Monitoring Project — Median test positivity by clinic for gonorrhea and chlamydia among MSM attending STD

clinics, by HIV status, 2001

M edian positivity

H IV -positive

H IV -negative or unknow n

0

5

10

15

20

25

U rethra lgonorrhea

R ecta lgonorrhea

Pharyngealgonorrhea

U rethra lch lam ydia

Gonococcal Isolate Surveillance Project (GISP) — Percent of gonorrhea cases that occurred among MSM, 1988-2001

Percent

0

4

8

12

16

20

1988 89 90 91 92 93 94 95 96 97 98 99 2000 01

Gonococcal Isolate Surveillance Project (GISP) — Percent of Neisseria gonorrhoeae isolates obtained from MSM attending STD

clinics in 16 cities, 1999, 2000, and 2001

Note: In 2001, these 16 clinics reported 95.2% (853/896) of GISP gonorrhea cases among men who have sex with men (MSM). Clinics include: ALB=Albuquerque, NM; ANC=Anchorage, AK; ATL=Atlanta, GA; CHI=Chicago, IL; DEN=Denver, CO; HON=Honolulu, HI; LBC=Long Beach, CA; MIA=Miami, FL; MIN=Minneapolis, MN; ORA=Orange County, CA; PHI=Philadelphia, PA; PHX=Phoenix, AZ; POR=Portland, OR; SDG=San Diego, CA; SEA=Seattle, WA; and SFO=San Francisco, CA.

Percent

1999

2000

2001

0

15

30

45

60

75

ALB AN C ATL C H I D E N H O N LBC M IA

C itiesM IN O R A PH I PH X PO R SD G SEA SFO

STDs in Persons Entering Corrections Facilities



Syphilis serologic tests — Percent seroreactivity in women entering juvenile and adult corrections facilities, 2001

Note: The median positivity is presented from facilities reporting >100 test results. Texas submitted data from more than one adult corrections facility. California submitted data from more than one juvenile corrections facility.

SOURCE: Jail STD Prevalence Monitoring Project; Local and State STD Control Programs; Centers for Disease Control and Prevention

4.4

0.6

7.4

10.5

1.6 7.1

22.2 9.3

21.2

6.7

2.3

10.0

MA

RINJ

MD

Adult Correctional Facility

Juvenile Correctional Facility

2.4

2.18.6

11.3

DECT

VT

ME

NH8.9

Syphilis serologic tests — Percent seroreactivity in men entering juvenile and adult corrections facilities, 2001

Note: The median positivity is presented from facilities reporting >100 test results. Mississippi and Texas submitted data from more than one adult corrections facility. California submitted data from more than one juvenile corrections facility.

SOURCE: Jail STD Prevalence Monitoring Project; Local and State STD Control Programs; Centers for Disease Control and Prevention

2.8

0.2

2.5

5.1

0.0 3.4

8.1 3.4

0.3

1.3 2.6

1.2

3.0



MA

RINJ

MD1.7

0.82.7

4.2

DECT

VT

ME

NH2.0

Chlamydia — Positivity in women entering juvenile and adult corrections facilities, 2001

Note: The median positivity is presented from facilities reporting >100 test results. Hawaii, Kansas, Pennsylvania, Massachusetts and Wisconsin submitted data from more than one adult corrections facility. California, Texas, Utah and Wisconsin submitted data from more than one juvenile corrections facility.

SOURCE: Jail STD Prevalence Monitoring Project; Adolescent Women Reproductive Health Monitoring Project; Regional Infertility Prevention Program; Local and State STD Control Programs; Centers for Disease Control and Prevention

6.8

14.0

2.5

3.9

2.1 8.6

0.5

6.9

4.8

0.5

5.2 8.5

5.7

6.8



9.6

21.7

17.0

5.8

17.5

8.1

21.0

23.9

4.5

22.1

12.1

24.1

21.5

3.6

MA

RINJ

MD

DECT

VT

ME

NH5.720.8

Chlamydia — Positivity in men entering juvenile and adult corrections facilities, 2001

Note: The median positivity is presented from facilities reporting >100 test results. Massachusetts, Tennessee and Wisconsin submitted data from more than one adult corrections facility. California, Illinois, Maryland, Oregon, Texas, Utah, Washington and Wisconsin submitted data from more than one juvenile corrections facility.


5.04.8

3.4

7.9

3.9

6.5

6.7

1.6

2.9 8.4

9.2

8.3



7.3

8.8

3.9

5.3

6.8

2.9

5.2

6.0

4.8

5.7

MA

RINJ

MD

DECT

VT

ME

NH7.67.4

6.9

Gonorrhea — Positivity in women entering juvenile and adult corrections facilities, 2001

Note: The median positivity is presented from facilities reporting >100 test results. Wisconsin submitted data from more than one adult corrections facility. California, Texas and Wisconsin submitted data from more than one juvenile corrections facility.


2.5

4.9

4.7

2.6

8.3

2.50.7

2.2

3.3

1.8

0.5

1.3 5.0

4.4

4.4



0.6

0.06.1

8.6

12.4

0.4 3.3

5.9

MA

RINJ

MD

DECT

VT

ME

NH

8.9

Gonorrhea — Positivity in men entering juvenile and adult corrections facilities, 2001

Note: The median positivity is presented from facilities reporting >100 test results. Wisconsin submitted data from more than one adult corrections facility. California, Colorado, Illinois, Kentucky, Maryland and Wisconsin submitted data from more than one juvenile corrections facility.


1.63.2

2.1

2.1

0.5

1.4 2.8

5.7

2.2



0.5

2.10.7

2.7

1.6

0.9

0.8

1.9 MA

RINJ

MD

DECT

VT

ME

NH

2.3

0.8

STDs in the South



South — Primary and secondary syphilis case rates by county, 2001

Rate per 100,000 population

<=0.20.21-4.0>4.0

(n=1,020)(n=233)(n=170)

South — Chlamydia case rates by county, 2001

Rate per 100,000 population<=150150.1-300>300

(n=489)(n=488)(n=446)

SOURCE: National Electronic Telecommunications System for Surveillance (NETSS) data

South — Gonorrhea case rates by county, 2001

Rate per 100,000 population

<=1919.1-100>100

(n=298)(n=497)(n=628)

SOURCE: National Electronic Telecommunications System for Surveillance (NETSS) data

NETSS



Chlamydia — National Electronic Telecommunications System for Surveillance (NETSS) transmission status by state, 2001

Note: Unless noted, large city projects transmit records in the same format as states. San Francisco and Los Angeles projects report case extended chlamydia records to NETSS.

Guam


NETSS Data: Summary Case Case Extended Discontinued Hardcopy

Gonorrhea — National Electronic Telecommunications System for Surveillance (NETSS) transmission status by state, 2001

Note: Unless noted, large city projects transmit records in the same format as states. San Francisco and Los Angeles projects report case extended gonorrhea records to NETSS.

Guam



Primary and secondary syphilis — National Electronic Telecommunications System for Surveillance (NETSS) transmission

status by state, 2001

Guam



Note: Unless noted, large city projects transmit records in the same format as states.

All Slides Sexually Transmitted Disease Surveillance 2001 Division of STD Prevention.

Documents